Status:
COMPLETED
Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion
Lead Sponsor:
Terumo BCT
Conditions:
Leukocytosis
Eligibility:
All Genders
Brief Summary
This study is a multicenter, retrospective data collection of routine clinical use with the Spectra Optia® apheresis system for white blood cell depletion.
Detailed Description
The goal of this study is to gather a broader knowledge and information from routine clinical use on the performance and safety of white blood cell depletion procedures with the Spectra Optia® apheres...
Eligibility Criteria
Inclusion
- Patients having received a minimum of 1 white blood cell depletion procedure via the Spectra Optia Apheresis System
Exclusion
- none
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT02302365
Start Date
April 1 2014
End Date
July 1 2017
Last Update
July 3 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Gasthuisberg
Leuven, Belgium, 3000
2
Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Johann-Wolfgang-Goethe-University Hospital
Frankfurt am Main, Germany, 60528
3
Szent Istvan and Szent Laszlo Hospital of Budapest
Budapest, Hungary, 1097